Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-02-13
1982-09-21
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
42424857, 544251, 544115, 544287, A61K 31505, C07D48704
Patent
active
043506950
ABSTRACT:
Novel triazoloquinazolinones of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, halogen, --NO.sub.2, methyl, methoxy and --CF.sub.3, n is an integer from 2 to 5, R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen and alkyl and hydroxyalkyl of 1 to 5 carbon atoms and taken together with the nitrogen atom to which they are attached form a saturated heterocycle optionally containing another heteroatom and optionally substituted with at least one member of the group consisting of hydroxy, alkyl and hydroxyalkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, acyl of an aliphatic carboxylic acid of 1 to 5 carbon atoms, alkoxycarbonyl of 2 to 6 carbon atoms and aryl optionally substituted with a halogen or --CF.sub.3 and their non-toxic, pharmaceutically acceptable acid addition salts having antihistaminic and bronchospasmolytic activity and their preparation.
REFERENCES:
patent: 3850932 (1974-11-01), Kathawala
Bowie, et al., Chemical Abstracts, vol. 92, 128148w (1980), J. Chem. Soc., Perkin Trans., 2/79 (12), pp. 1708-1714.
Murdoch Robert
Tully Wilfred R.
Westwood Robert
Gerstl Robert
Rivers Diana G.
Roussel Uclaf
LandOfFree
Antihistaminic and bronchospasmolytic triazoloquinazolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihistaminic and bronchospasmolytic triazoloquinazolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihistaminic and bronchospasmolytic triazoloquinazolinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2076287